SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-031905
Filing Date
2024-08-14
Accepted
2024-08-14 08:41:20
Documents
16
Period of Report
2024-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39994
2 ex99-1.htm EX-99.1 80264
3 ex99-1_001.jpg GRAPHIC 3923
  Complete submission text file 0001493152-24-031905.txt   312270

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sonn-20240814.xsd EX-101.SCH 3018
5 XBRL LABEL FILE sonn-20240814_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE sonn-20240814_pre.xml EX-101.PRE 22361
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3700
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 241204384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)